A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Carboplatin|DRUG: Docetaxel|DRUG: Pertuzumab|DRUG: Trastuzumab|DRUG: Trastuzumab Emtansine
Sponsor: Hoffmann-La Roche